SF:NYSEStifel Financial Corporation Analysis
Data as of 2026-09-01 - not real-time
$78.84
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
At $78.84, Stifel Financial Corp. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. The last 30 days have gained 1.6%. RSI sits at 40.6, which reads as neutral, and MACD momentum is bearish. The recent range runs from support at $78.53 up to resistance at $86.19.
The shares look undervalued, trading on 14.1 times earnings below a sector average of 16.7. Sell-side targets cluster 12.9% above the current quote. Revenue is growing at 12.7% on a 16.3% profit margin. The 1.68% dividend yield looks covered by current payout levels.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 23.8%, a beta of 1.02 and a maximum drawdown of 23.5%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 7 out of 10.
The shares look undervalued, trading on 14.1 times earnings below a sector average of 16.7. Sell-side targets cluster 12.9% above the current quote. Revenue is growing at 12.7% on a 16.3% profit margin. The 1.68% dividend yield looks covered by current payout levels.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 23.8%, a beta of 1.02 and a maximum drawdown of 23.5%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 7 out of 10.
Top Market Events
Financial services firm Stifel Financial NYSE:SF reported in Q2 CY2026, with sales up 13% year on year to $1.ST. LOUIS, Aug. 05, 2026 GLOBE NEWSWIRE -- Stifel Financial Corp. NYSE: SF today announced that its Board of Directors...Stifel Financial SF stock is in focus after the company reported second quarter 2026 results that exceeded revenue and...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 78.65
- MACD momentum is negative
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 14.1 versus sector average of 16.7
- Trading above the 200-day average of 78.65
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- P/E of 14.1 versus sector average of 16.7
- Analyst targets imply +12.9% versus the current price
- Profit margin of 16.3% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth12.70%
Profit Margin16.34%
P/E Ratio14.1
ROE16.43%
ROA2.25%
Debt/Equity52.00
P/B Ratio2.2
Op. Cash Flow$454.3M
Industry P/E16.7
Technical Analysis
TrendBullish
RSI40.6
Support$78.53
Resistance$86.19
MA 20$82.46
MA 50$79.13
MA 200$78.65
MACDBearish
VolumeIncreasing
Fear & Greed Index92.25
Valuation
Fair Value$59.30
Target Price$89.00
Upside/Downside12.89%
GradeUndervalued
TypeBlend
Dividend Yield1.68%
Risk Assessment
Beta1.02
Volatility23.76%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.